Larson Financial Group LLC bought a new position in shares of The Chemours Company (NYSE:CC – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,101 shares of the specialty chemicals company’s stock, valued at approximately $205,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. State of New Jersey Common Pension Fund D boosted its stake in Chemours by 39.1% in the third quarter. State of New Jersey Common Pension Fund D now owns 101,670 shares of the specialty chemicals company’s stock valued at $2,066,000 after acquiring an additional 28,591 shares in the last quarter. GSA Capital Partners LLP acquired a new position in Chemours in the third quarter valued at $1,615,000. Victory Capital Management Inc. boosted its stake in Chemours by 206.2% in the third quarter. Victory Capital Management Inc. now owns 103,259 shares of the specialty chemicals company’s stock valued at $2,098,000 after acquiring an additional 69,531 shares in the last quarter. Oppenheimer & Co. Inc. acquired a new position in Chemours in the third quarter valued at $285,000. Finally, KBC Group NV boosted its stake in Chemours by 19.5% in the third quarter. KBC Group NV now owns 4,468 shares of the specialty chemicals company’s stock valued at $91,000 after acquiring an additional 728 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have issued reports on CC shares. Truist Financial started coverage on shares of Chemours in a research note on Tuesday, January 28th. They issued a “buy” rating and a $27.00 price objective for the company. Barclays decreased their price objective on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, February 24th. The Goldman Sachs Group reduced their target price on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, Mizuho reduced their target price on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.11.
Chemours Stock Up 1.8 %
CC stock opened at $13.69 on Wednesday. The company’s 50 day simple moving average is $17.38 and its 200-day simple moving average is $18.59. The firm has a market capitalization of $2.05 billion, a PE ratio of 24.02 and a beta of 2.00. The Chemours Company has a 12 month low of $13.09 and a 12 month high of $29.21. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.
Chemours (NYSE:CC – Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. Equities analysts expect that The Chemours Company will post 2.03 earnings per share for the current fiscal year.
Chemours Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.30%. The ex-dividend date of this dividend is Friday, February 28th. Chemours’s dividend payout ratio is presently 175.44%.
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Further Reading
- Five stocks we like better than Chemours
- What to Know About Investing in Penny Stocks
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC – Free Report).
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.